AI assistant
Sending…
ULTRALIFE CORP — Director's Dealing 2009
Apr 16, 2009
34105_dirs_2009-04-16_0fcda05a-f3e8-4115-a04c-0c59c929b882.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2009-04-16
Reporting Person: SCHMITZ WILLIAM A (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-04-16 | Common Stock; $.10 par value | M | 6250 | $4.96 | Acquired | 36316 | Direct |
| 2009-04-16 | Common Stock; $.10 par value | F | 4657 | $8.06 | Disposed | 31659 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-04-16 | Stock Option (Right to Buy) | $4.96 | M | 4657 | Disposed | 2009-04-25 | Common stock; $.10 par value (0) | Direct |
Footnotes
F1: Represents the total number of shares acquired prior to the cashless exercise of 6250 shares.
F2: The shares were sold to the issuer and were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.96.
More from ULTRALIFE CORP
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 29
Annual Report
2026
Mar 23
Major Shareholding Notification
2026
Mar 17
Regulatory Filings
2026
Mar 16
Regulatory Filings
2026
Mar 10
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Jan 5
Director's Dealing
2025
Dec 16